138
Views
18
CrossRef citations to date
0
Altmetric
Original Research

Angiotensin-(1–7) Analogue AVE0991 Modulates Astrocyte-Mediated Neuroinflammation via lncRNA SNHG14/miR-223-3p/NLRP3 Pathway and Offers Neuroprotection in a Transgenic Mouse Model of Alzheimer's Disease

, ORCID Icon, , , , , , , ORCID Icon, , & show all
Pages 7007-7019 | Published online: 18 Dec 2021

References

  • Jiang T, Yu JT, Tian Y, Tan L. Epidemiology and etiology of alzheimer’s disease: from genetic to non- genetic factors. Curr Alzheimer Res. 2013;10(8):852–867. doi:10.2174/15672050113109990155
  • Leng F, Edison P. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Rev Neurol. 2021;17(3):157–172. doi:10.1038/s41582-020-00435-y
  • Brod SA. Anti-inflammatory agents: an approach to prevent cognitive decline in alzheimer’s disease. J Alzheimer’s Dis. 2021;1–16. doi:10.3233/JAD-215125
  • Schweda F. Salt feedback on the renin-angiotensin-aldosterone system. Pflugers Archiv. 2015;467(3):565–576. doi:10.1007/s00424-014-1668-y
  • Loera-Valencia R, Eroli F, Garcia-Ptacek S, Maioli S. Brain renin-angiotensin system as novel and potential therapeutic target for alzheimer’s disease. Int J Mol Sci. 2021;22(18):10139. doi:10.3390/ijms221810139
  • Xu P, Sriramula S, Lazartigues E. ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good. research support, N.I.H., extramural review. Am J Physiol Regul Integr Comp Physiol. 2011;300(4):R804–17. doi:10.1152/ajpregu.00222.2010
  • Santos RA, Simoes e Silva AC, Maric C, et al. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Research Support, Non-U.S. Gov’t. Proc Natl Acad Sci U S A. 2003;100(14):8258–8263. doi:10.1073/pnas.1432869100
  • Jiang T, Tan L, Gao Q, et al. Plasma Angiotensin-(1-7) is a potential biomarker for alzheimer’s disease. Curr Neurovasc Res. 2016;13(2):96–99. doi:10.2174/1567202613666160224124739
  • Jiang T, Xue LJ, Yang Y, et al. AVE0991, a nonpeptide analogue of Ang-(1-7), attenuates aging-related neuroinflammation. Aging. 2018;10(4):645–657. doi:10.18632/aging.101419
  • Jiang T, Zhang YD, Zhou JS, et al. Angiotensin-(1-7) is reduced and inversely correlates with tau hyperphosphorylation in animal models of alzheimer’s disease. Mol Neurobiol. 2016;53(4):2489–2497. doi:10.1007/s12035-015-9260-9
  • Duan R, Xue X, Zhang QQ, et al. ACE2 activator diminazene aceturate ameliorates Alzheimer’s disease-like neuropathology and rescues cognitive impairment in SAMP8 mice. Aging. 2020;12(14):14819–14829. doi:10.18632/aging.103544
  • Kwon HS, Koh SH. Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes. Transl Neurodegener. 2020;9(1):42. doi:10.1186/s40035-020-00221-2
  • Moore ED, Kooshki M, Metheny-Barlow LJ, Gallagher PE, Robbins ME. Angiotensin-(1-7) prevents radiation-induced inflammation in rat primary astrocytes through regulation of MAP kinase signaling. Free Radic Biol Med. 2013;65:1060–1068. doi:10.1016/j.freeradbiomed.2013.08.183
  • Chen Z, Wu H, Zhang M. Long non-coding RNA: an underlying bridge linking neuroinflammation and central nervous system diseases. Neurochem Int. 2021;148:105101. doi:10.1016/j.neuint.2021.105101
  • Xie W, Wu D, Ren Y, et al. OIP5-AS1 attenuates microangiopathy in diabetic mouse by regulating miR-200b/ACE2. World Neurosurg. 2020;139:e52–e60. doi:10.1016/j.wneu.2020.03.063
  • Li W, Wang R, Ma JY, et al. A human long non-coding RNA ALT1 controls the cell cycle of vascular endothelial cells via ACE2 and cyclin D1 pathway. Cell Physiol Biochem. 2017;43(3):1152–1167. doi:10.1159/000481756
  • Vickers C, Hales P, Kaushik V, et al. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem. 2002;277(17):14838–14843. doi:10.1074/jbc.M200581200
  • Jiang T, Tan L, Zhu XC, et al. Upregulation of TREM2 ameliorates neuropathology and rescues spatial cognitive impairment in a transgenic mouse model of Alzheimer’s disease. Neuropsychopharmacology. 2014;39(13):2949–2962. doi:10.1038/npp.2014.164
  • Xue X, Duan R, Zhang QQ, et al. A non-peptidic MAS1 agonist AVE0991 alleviates hippocampal synaptic degeneration in rats with chronic cerebral hypoperfusion. Curr Neurovasc Res. 2021;18. doi:10.2174/1567202618666211012095210
  • Larson ME, Lesne SE. Soluble Abeta oligomer production and toxicity. Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t Review. J Neurochem. 2012;120 Suppl 1:125–139. doi:10.1111/j.1471-4159.2011.07478.x
  • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–408. doi:10.1006/meth.2001.1262
  • Kim D, Langmead B, Salzberg SL. HISAT: a fast spliced aligner with low memory requirements. Nat Methods. 2015;12(4):357–360. doi:10.1038/nmeth.3317
  • Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. doi:10.1186/s13059-014-0550-8
  • Yang CC, Lin CC, Hsiao LD, Kuo JM, Tseng HC, Yang CM. Lipopolysaccharide-induced matrix metalloproteinase-9 expression associated with cell migration in rat brain astrocytes. Int J Mol Sci. 2019;21(1). doi:10.3390/ijms21010259
  • Zhu J, Hu Z, Han X, et al. Dopamine D2 receptor restricts astrocytic NLRP3 inflammasome activation via enhancing the interaction of beta-arrestin2 and NLRP3. Cell Death Differ. 2018;25(11):2037–2049. doi:10.1038/s41418-018-0127-2
  • Heneka MT, Kummer MP, Stutz A, et al. NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice. Nature. 2013;493(7434):674–678. doi:10.1038/nature11729
  • Jin Y, Zhang M, Duan R, et al. Long noncoding RNA FGF14-AS2 inhibits breast cancer metastasis by regulating the miR-370-3p/FGF14 axis. Cell Death Discov. 2020;6:103. doi:10.1038/s41420-020-00334-7
  • Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014;505(7483):344–352. doi:10.1038/nature12986
  • Evans CE, Miners JS, Piva G, et al. ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer’s disease. Acta Neuropathol. 2020;139(3):485–502. doi:10.1007/s00401-019-02098-6
  • Cao C, Hasegawa Y, Hayashi K, Takemoto Y, Kim-Mitsuyama S. Chronic angiotensin 1-7 infusion prevents angiotensin-ii-induced cognitive dysfunction and skeletal muscle injury in a mouse model of alzheimer’s disease. J Alzheimer’s Dis. 2019;69(1):297–309. doi:10.3233/JAD-181000
  • Uekawa K, Hasegawa Y, Senju S, et al. Intracerebroventricular infusion of angiotensin-(1-7) ameliorates cognitive impairment and memory dysfunction in a mouse model of alzheimer’s disease. J Alzheimer’s Dis. 2016;53(1):127–133. doi:10.3233/JAD-150642
  • Ho JK, Nation DA. Cognitive benefits of angiotensin IV and angiotensin-(1-7): a systematic review of experimental studies. Neurosci Biobehav Rev. 2018;92:209–225. doi:10.1016/j.neubiorev.2018.05.005
  • da Silveira KD, Coelho FM, Vieira AT, et al. Anti-inflammatory effects of the activation of the angiotensin-(1-7) receptor, MAS, in experimental models of arthritis. J Immunol. 2010;185(9):5569–5576. doi:10.4049/jimmunol.1000314
  • Jawien J, Toton-Zuranska J, Gajda M, et al. Angiotensin-(1-7) receptor Mas agonist ameliorates progress of atherosclerosis in apoE-knockout mice. J Physiol Pharmacol. 2012;63(1):77–85.
  • Rodrigues-Machado MG, Magalhaes GS, Cardoso JA, et al. AVE 0991, a non-peptide mimic of angiotensin-(1-7) effects, attenuates pulmonary remodelling in a model of chronic asthma. Br J Pharmacol. 2013;170(4):835–846. doi:10.1111/bph.12318
  • Zhang M, Zhu X, Tong H, et al. AVE 0991 attenuates pyroptosis and liver damage after heatstroke by inhibiting the ROS-NLRP3 inflammatory signalling pathway. Biomed Res Int. 2019;2019:1806234. doi:10.1155/2019/1806234
  • Tan MS, Yu JT, Jiang T, Zhu XC, Tan L. The NLRP3 inflammasome in Alzheimer’s disease. Mol Neurobiol. 2013;48(3):875–882. doi:10.1007/s12035-013-8475-x
  • Kuwar R, Rolfe A, Di L, et al. A novel inhibitor targeting NLRP3 inflammasome reduces neuropathology and improves cognitive function in alzheimer’s disease transgenic mice. J Alzheimer’s Dis. 2021;82(4):1769–1783. doi:10.3233/JAD-210400
  • Oo JA, Brandes RP, Leisegang MS. Long non-coding RNAs: novel regulators of cellular physiology and function. Pflugers Archiv. 2021. doi:10.1007/s00424-021-02641-z
  • Yan H, Rao J, Yuan J, et al. Long non-coding RNA MEG3 functions as a competing endogenous RNA to regulate ischemic neuronal death by targeting miR-21/PDCD4 signaling pathway. Cell Death Dis. 2017;8(12):3211. doi:10.1038/s41419-017-0047-y
  • Li JW, Ren SH, Ren JR, et al. Nimodipine improves cognitive impairment after subarachnoid hemorrhage in rats through IncRNA NEAT1/miR-27a/MAPT axis. Drug Des Devel Ther. 2020;14:2295–2306. doi:10.2147/DDDT.S248115
  • Han CL, Ge M, Liu YP, et al. Long non-coding RNA H19 contributes to apoptosis of hippocampal neurons by inhibiting let-7b in a rat model of temporal lobe epilepsy. Cell Death Dis. 2018;9(6):617. doi:10.1038/s41419-018-0496-y
  • Lv K, Liu Y, Zheng Y, Dai S, Yin P, Miao H. Long non-coding RNA MALAT1 regulates cell proliferation and apoptosis via miR-135b-5p/GPNMB axis in Parkinson’s disease cell model. Biol Res. 2021;54(1):10. doi:10.1186/s40659-021-00332-8
  • Zhang YY, Bao HL, Dong LX, Liu Y, Zhang GW, An FM. Silenced lncRNA H19 and up-regulated microRNA-129 accelerates viability and restrains apoptosis of PC12 cells induced by Aβ in a cellular model of Alzheimer’s disease. Cell Cycle. 2021;20(1):112–125. doi:10.1080/15384101.2020.1863681
  • Wu ZM, Luo J, Shi XD, Zhang SX, Zhu XB, Guo J. Icariin alleviates rheumatoid arthritis via regulating miR-223-3p/NLRP3 signalling axis. Autoimmunity. 2020;53(8):450–458. doi:10.1080/08916934.2020.1836488
  • Chen L, Hou X, Zhang M, et al. MicroRNA-223-3p modulates dendritic cell function and ameliorates experimental autoimmune myocarditis by targeting the NLRP3 inflammasome. Mol Immunol. 2020;117:73–83. doi:10.1016/j.molimm.2019.10.027